which have the typical structure of pectin (5, 6) . In 2012, several water-soluble ginseng oligosaccharides with a degree of polymerization ranging from 2 to 10 were obtained from a warm-water extract of ginseng roots, among them, α-Glcp-(1-6)-α-Glcp, α-Glcp-(1-6)-α-Glcp-(1-4)-α-Glcp, α-Glcp-(1-6)-α-Glcp-(1-6)-α-Glcp-(1-4)-α-Glcp, and another six malto-oligosaccharides (i.e., maltopentaose, maltohexaose, maltoheptaose, maltooctaose, maltononaose, maltodecaose) were detected (7).
Ginsenosides
Ginsenosides, known as saponins, are considered to be the major bioactive constituents of ginseng. The first saponin isolated from ginseng could be traced back to -glc(2-1)glc -glc(2-1)glc -glc(2-1)glc -glc(2-1)glc(6) Bu -glc(2-1)glc(6) Ac -glc(2-1)glc(6) Bu -glc(2-1)glc(6) Bu -glc(2-1)glc(4) Bu -glc(2-1)glc(6)Bu -glc(2-1)glc -glc(2-1)glc -glc(2-1)glc -glc(2-1)glc -glc(2-1)glc -glc(2-1)glc -glc(2-1)glc -glc -glc -glc(2-1)glc(6) Ac -glc(2-1)glc(6) Ac -glc(2-1)glc(6) Ac -glc(2-1)glc(6) mal -glc(2-1)glc(6) mal -glc(2-1)glc(6) mal -glc(2-1)glc(6) mal -glc(2-1)glc(6) mal -glc(2-1)glc(6) mal -glc -glc -glc(2-1)glc -glc(2-1)glc(6) Ac -glc(2-1)glc(6) Ac -glc(2-1)xyl -glc(2-1) rha -glc -glc(3-1) glc -glc -glc -glc -glc(2-1) glc -glc -glc(2-1) rha -glc(2-1) rha -glc(2-1) glc -glc -glc -glc(6-1) Bu -glc(4-1) glc -glc(2-1) xyl -glc(2-1) xyl -glc(6)Ac Name 20S 27 12,18,27 25,27 27 (to continue) Rg 6 are known to be unique constituents of red ginseng (10) . Names of the compounds and their corresponding reference are compiled in Table 1 , and structures of 1-70 are shown in Figure 1. 
Alkaloids
In 1986, three β-carboline alkaloids were isolated from the root of ginseng by Han et al. for the first time (40, 41) . In the following year, two other β-carboline alkaloids were reported by Jong et al. (42, 43) . Their structures, 71-75, are shown in Figure 1. 
Glucosides
Based on spectral and chemical evidence, three 1854 (3). Later, the chemical structures of several ginseng saponins were characterized in the 1960s (8) . Saponin components are a type of triterpenoidal dammarane glycosides, named ginsengosides Rx according to their mobility on TLC plates, with polarity decreasing from "a" to "h" (9) . According to the positioning of sugar moieties at carbon -3 and -6, ginsenosides can be divided into protopanaxadiol type (protopanaxadiol type, I-1 type) and protopanaxatriol type (protopanaxatriol type, I-2 type); since the I-1 and I-2-type chiral carbon C-20 position substituted poor isobutyl, and is further divided into 20 (S) and 20 (R). To date, more than 70 ginsenosides, 1-70, have been isolated from the three main kinds of ginseng, among them, ginsenosides Rb l , Rb 2 , Rc, Rd, Rgl, Rg 2 , and Re are major constituents of white and red ginsengs, while ginsenosides Rg 3 , Rg 5 , and 
I-2-2 ginsenoside Re 5 I-2-3 ginsenoside Rf 2 I-2-4 ginsenoside Rg 5 I-1-1 ginsenoside Rg 6 I-2-5 ginsenoside Rh 4 I-2-6 ginsenoside Rk 1 I-1-2 ginsenoside Rk 2 I-1-3 ginsenoside Rk 3 I-2-7 ginsenoside Rs 4 I-1-4 ginsenoside Rs 5 I-1-5 ginsenoside Rs 6 I-2-8 ginsenoside Rs 7 I-2-9 koryoginsenosideR 2 I-1-6
ginsenoside Ro II-1 ginsenoside Ri II-1 ginsenoside Romethyl ester II-1 polyacetyleneginsenoside-Ro II-1 glycosides isolated from red ginseng were characterized as isomaltol-α-D-glucopyranoside (76), ketopropyl-α-D -glucopyranoside (77) and adenosine (78) . However, these compounds are not found in white ginseng (44,45).
Phenolic acid
In 1979, maltol (3-hydroxy-2-methyl-4-pyrone) (79) was isolated from ginseng (46) . In 1981, another three phenolic acids were obtained from the ether-soluble acidic fraction of fresh ginseng, and they were identified by chemical and spectrometric methods to be salicylic acid (80) , vanillic acid (81), and p-hydroxycinnamic acid (82) (47).
Others
Besides all the constituents listed above, in 1988, a thiazole (83) was isolated by Jong et al. (43) . In 1990, two lingans were isolated from Korean red ginseng and their chemical structures were elucidated as gomisin N (84) and gomisin A (85) by spectrometric analysis (48).
Biological activities

Anti-aging activity
Ginseng, as a well-known traditional medicine and tonic, has been used for a panacea or promoting longevity. Abundant evidence suggested that oxidative stress plays a central role in the process of biological aging (49) . Excessive oxidative stress leads to cell death and mitochondrial dysfunction (50) . Some research indicated that ginseng extracts had been shown to improve learning and memory in normal, aged or brain-damaged animals (51, 52 
Immunoregulatory activity
Ginseng has been used for more than 2000 years in oriental countries to enhance stamina and immune function. In 1994, the antigenicity of the aqueous extract of red ginseng (ARG) was evaluated in guinea pigs, the results suggested that ARG has no antigenicity but it was confirmed not to suppress immune reactions (64) . Ginsan, a polysaccharide isolated from ginseng, had been shown to be a potent immunomodulator, producing several cytokines (tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), interleukin-2 (IL-2), interleukin-6 (IL-6), interleukin-12 (IL-12), interferon-γ (IFN-γ), granulocyte-macrophage colony-stimulating factor (GM-CSF)) and stimulating lymphoid cells to proliferate (65) . In 2004, the mechanism of the immunomodulator activity of ginsan was investigated, and the results showed that ginsan at a dose of 100 mg/kg could cause marked elevation (1.7-2 fold) of heme oxygenase (HO) activity, decrease total hepatic cytochrome P-450 (CYP450) levels (by 20-34%), and prolong zoxazolamine-induced paralysis time (by 65-70%), and did not seem to cause hepatic injury, since serum aspartate aminotransferase (AST), alanineaminotransferase (ALT), and alkaline phosphatase (ALP) activities and levels of total bilirubin and albumin were not changed (66 (10) , Rc (13) and Re (34) could act as a weak phytoestrogen in MCF-7 human breast cancer cells by binding and activating the estrogen receptors at both the mRNA and protein levels (72, 73) . In 2004, it was found that ginsenoside Rg 3 (15/16) and Rh 2 (17/18)-induced cell detachment and inhibition of the proliferation of prostate cancer cells and might be associated with modulation of three modules of MAP kinases (extracellular signal-regulated kinase, p38 mitogen-activated protein kinase, and c-Jun N-terminal kinase). Furthermore, the increase of LogP and decrease of C-6 steric hindrance, which were caused by deglycosylation by intestinal bacteria could increase antiandrogen-independent prostate cancer activity (74, 75) . In 2005, compound K, ginsenoside metabolite, was found to inhibit the growth of human monocytic leukemia cells U937 through up-regulating of p21 and activating Jun N-terminal kinase in the G1 phase (76) . Rg 3 (15/16) was discovered to inhibit tumor cell proliferation and induce cell apoptosis in mice with induced liver cancer (77 
Lipid-regulating and antithrombotic activities
It was found that ginseng saponin, one of major component of Panax ginseng had influence on lipid metabolism. Saponin stimulated the absorption, metabolism and transport of lipids (86) . It had been also reported that ginseng saponin decreased plasma cholesterol and triglyceride levels and inhibited aortic atheroma formation in animals with hypercholesterolemia caused by long administration of high cholesterol or feeding on a diet containing high cholesterol (86) . In 1984, it was reported that red ginseng saponin showed no significant change of high-density lipoproteincholesterol-cholesterol (HDL-cholesterol) level but it lowered plasma levels of total cholesterol and highly elevated those of triglyceride in Wistar male rats fed on a diet high in cholesterol and triglyceride (86) . In 2006, it was identified that Rg 3 (15/16) might be effective in metabolic syndrome (MetSyn) by comparing the anti-MetSyn effect of vinegar-processed ginseng radix and non-processed ginseng radix in a high fat diet induced MetSyn ICR mouse model (87) . In the same year, it was reported that red ginseng had a potent antithrombotic effect in vivo, which may be due to antiplatelet rather than anticoagulation activity, and its intake may be beneficial to individuals with high risk of thrombotic and cardiovascular diseases (88).
Wound and ulcer healing activity
In 2002, it was reported that ginsenoside Rb 2 (11) could enhance epidermal cell proliferation by upregulating the expression of proliferation-related factors (89). (90) . In 2003, Rb 1 (10) was found to exhibit an anti-ulcer effect through increasing mucus secretion (91,92).
Other activities
In 1986, Lee et al. reported that ginseng saponin could interact directly with Na + -K + -ATPase before disruption of membrane barriers of sarcolemmal vesicles, however, it decreased the number of phosphorylation sites (93) . In 1996, it was reported that GTS could modulate various cellular activities by inhibiting gap junction channel reconstitution (94) . In 2001, Ginseng saponin had been reported to induce IP 3 -mediated Ca 2+ release from ERs for the activation of Ca 2+ -activated Cl-channel in Xenopus oocytes (95, 96) . Furthermore, it was found that CaM could modulate ginseng saponinmediated Ca 2+ -activated Cl -channel activation (97) . In 2003, Rc (13) was found to enhance I GABA in oocytes expressing human GABA A receptor in Xenopus oocytes (98) . In 2006, it was reported that tissue culture root of wild Panax ginseng had feasibility as a therapeutic agent for spermatogenic disorders (99).
Conclusions
Panax ginseng (C. A. Mey.) has been used as traditional Chinese medicine for more than two thousand years. More than a hundred compounds were isolated from the root of ginseng, and a majority of them were ginsenosides, which showed a broad range of biological activities. Nevertheless, further studies to exploit other kinds of constituents and new biological activities of ginseng are still necessary to facilitate research and development in the future.
